Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7429 p657
2 December 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Consultation begins on the future structure of PECs

Fit to Lead

The consultation was launched last week

Consultation on a review of primary care trust (PCT) professional executive committees (PECs) in England began last week when the NHS Alliance, on behalf of the Department of Health, published “Fit to lead”, a review of PECs informed by the opinions and experiences of key stakeholders, including pharmacists.

Reconfiguration of PCTs, the move to practice-based commissioning and the success of some PECs, but not others, are reasons cited by the DoH for its review (PJ, 16 September, p325). Indeed, there is consensus among contributors to the review that PECs need to change to reflect the changing roles of PCTs.

There is also agreement that a flexible approach is needed. “PCTs vary hugely in their population size, geography and health needs. Prescriptive advice from the DoH should be kept to a minimum, although guiding principles and facilitation are essential,” says the consultation paper.

The paper was launched at the NHS Alliance conference held in Bournemouth last week. During a session entitled “Engaging clinicians in the newly reconfigured PCTs”, Gary Belfield, head of primary care at the Department of Health and lead for the review, reassured participants that the DoH does not yet have a view on the future structure and functions of PECs. “The only view we have is that PECs are needed — it is a blank sheet of paper,” he said.

Several PEC chairmen at the conference expressed concern that the committees would end up being constituted of mainly GPs with little input from other professionals. However, Mr Belfield confirmed that the DoH recognises the importance of multiprofessional involvement in PECs. “We need to think about how to get a broad church of people involved — the DoH is interested in that,” he said.

Mark Bulmore, a pharmacist and chairman of the professional executive committee at South East Essex PCT, believes that the review offers an opportunity to ensure that community pharmacists, as clinical leaders in primary care, continue to be involved in these committees. “The DoH has not yet made up its mind about the future structure of PECs. It is therefore important that pharmacists respond to the consultation in order to ensure that they continue to play an important role in future PECs,” he told The Journal.

The national pharmacy bodies produced a joint response to inform the review, which highlighted the inherent conflict of interest in many practices taking on both a commissioning and a provider role under practice-based commissioning. They argue that, since PCTs remain accountable financially for the decisions of their constituent commissioning groups, the new PECs could play a key role in scrutinising decisions made within these groups. This, they say, would give PCTs confidence that commissioning plans take into account the full range of delivery options and ensure value for money. To be effective in this new role, they say, the PEC should be a cross professional and sectoral forum involving providers and frontline clinicians rather than PCT employees. No one profession should be in the majority.

The full consultation document can be accessed at the DoH website. Responses to the key questions must be received by 7 February 2007.


News feature p662

Back to Top


©The Pharmaceutical Journal